ACETAMINOPHEN, CAFFEINE

ACETAMINOPHEN, CAFFEINE was reported 7820 times

ACETAMINOPHEN, CAFFEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTRACRANIAL VENOUS SINUS STENOSIS 7 0.3889
1 MEDICATION OVERUSE HEADACHE 149 0.1741
2 POSTNATAL GROWTH RESTRICTION 13 0.0992
3 BLOOD CAFFEINE INCREASED 4 0.0714
4 DRUG EFFECT VARIABLE 50 0.0441
5 OPTIC DISC HAEMORRHAGE 7 0.0306
6 EMERGENCY CARE EXAMINATION 17 0.0251
7 LARYNGITIS FUNGAL 3 0.0233
8 THUNDERCLAP HEADACHE 6 0.0229
9 BLOOD ZINC DECREASED 4 0.0220
10 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 7 0.0140
11 NONREASSURING FOETAL HEART RATE PATTERN 3 0.0135
12 BLOOD VISCOSITY DECREASED 4 0.0119
13 ADHESIVE TAPE USE 4 0.0104
14 DRUG WITHDRAWAL HEADACHE 4 0.0096
15 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 18 0.0091
16 HEMIPLEGIC MIGRAINE 3 0.0088
17 PERFORATED ULCER 6 0.0079
18 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 8 0.0075
19 MEDICAL DEVICE SITE PAIN 4 0.0071
20 ULCER HAEMORRHAGE 48 0.0071
21 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 157 0.0054
22 PRODUCT USED FOR UNKNOWN INDICATION 6 0.0048
23 GESTATIONAL HYPERTENSION 6 0.0046
24 GASTRIC PERFORATION 12 0.0044
25 REBOUND ACID HYPERSECRETION 13 0.0043
26 FOETAL HEART RATE DECELERATION ABNORMALITY 3 0.0042
27 IDIOPATHIC INTRACRANIAL HYPERTENSION 9 0.0040
28 OBSTRUCTION GASTRIC 5 0.0039
29 ESSENTIAL HYPERTENSION 7 0.0038
30 ULCER 60 0.0038
31 AORTIC DILATATION 4 0.0036
32 GINGIVAL ERYTHEMA 3 0.0035
33 ANOGENITAL WARTS 3 0.0034
34 GASTRIC OPERATION 3 0.0033
35 GASTRIC ULCER PERFORATION 4 0.0032
36 DRUG EFFECT DELAYED 14 0.0031
37 EPIGASTRIC DISCOMFORT 12 0.0031
38 NEPHROGENIC ANAEMIA 14 0.0030
39 MIGRAINE 287 0.0030
40 CLUSTER HEADACHE 4 0.0029
41 THERAPEUTIC PRODUCT EFFECT VARIABLE 11 0.0028
42 ALLERGY TO ANIMAL 3 0.0028
43 GASTRITIS EROSIVE 13 0.0028
44 AURA 5 0.0027
45 HYPERCOAGULATION 5 0.0026
46 THERAPEUTIC RESPONSE UNEXPECTED 117 0.0026
47 MIGRAINE WITH AURA 7 0.0026
48 GASTRIC ULCER HAEMORRHAGE 14 0.0025
49 GASTRIC ULCER 47 0.0025
50 EXPIRED DRUG ADMINISTERED 12 0.0024
51 HYPERPARATHYROIDISM SECONDARY 6 0.0024
52 GASTRIC DISORDER 81 0.0024
53 CALCIUM DEFICIENCY 3 0.0023
54 FEELING JITTERY 44 0.0023
55 OTORRHOEA 4 0.0023
56 GASTROINTESTINAL ULCER 5 0.0023
57 LYMPHOCYTE PERCENTAGE DECREASED 3 0.0022
58 PRODUCT TAMPERING 4 0.0022
59 PAPILLOEDEMA 10 0.0022
60 INFUSION SITE RASH 3 0.0022
61 GASTRIC HAEMORRHAGE 25 0.0022
62 FAT TISSUE INCREASED 3 0.0021
63 DEVICE RELATED SEPSIS 4 0.0020
64 TORTICOLLIS 4 0.0019
65 SNORING 7 0.0018
66 OESOPHAGEAL DISORDER 7 0.0018
67 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0018
68 ARTHROPOD STING 3 0.0018
69 PRODUCT PACKAGE ASSOCIATED INJURY 4 0.0018
70 MENINGITIS ASEPTIC 8 0.0018
71 INCORRECT DRUG ADMINISTRATION DURATION 50 0.0018
72 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 96 0.0017
73 HYPERURICAEMIA 7 0.0017
74 END STAGE RENAL DISEASE 31 0.0017
75 BLOOD HIV RNA INCREASED 3 0.0017
76 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 11 0.0016
77 LYMPH NODE PAIN 3 0.0016
78 CHRONIC SINUSITIS 6 0.0016
79 CONTRAINDICATED PRODUCT ADMINISTERED 48 0.0016
80 PARANASAL SINUS DISCOMFORT 6 0.0016
81 THERAPEUTIC RESPONSE CHANGED 10 0.0016
82 DRUG INEFFECTIVE 2064 0.0016
83 CANCER PAIN 4 0.0016
84 HYPOREFLEXIA 3 0.0016
85 OESOPHAGEAL ULCER 6 0.0016
86 ATROPHY 3 0.0015
87 DRUG EFFECT INCOMPLETE 56 0.0015
88 THERAPEUTIC PRODUCT EFFECT DELAYED 7 0.0015
89 DRUG ADMINISTRATION ERROR 46 0.0015
90 WEIGHT BEARING DIFFICULTY 4 0.0015
91 HEPATIC CYST 5 0.0015
92 GESTATIONAL DIABETES 7 0.0015
93 CLUMSINESS 4 0.0015
94 CHRONIC KIDNEY DISEASE 111 0.0015
95 DRUG SCREEN FALSE POSITIVE 4 0.0014
96 VITAMIN D DEFICIENCY 14 0.0014
97 LIVE BIRTH 12 0.0014
98 INCORRECT DOSAGE ADMINISTERED 7 0.0014
99 APPLICATION SITE BURN 7 0.0014
100 INFUSION SITE BRUISING 3 0.0014
101 FIBULA FRACTURE 4 0.0014
102 PRODUCT PHYSICAL ISSUE 28 0.0014
103 PARAPLEGIA 4 0.0014
104 MIDDLE EAR EFFUSION 3 0.0014
105 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
106 DRUG EFFECT LESS THAN EXPECTED 20 0.0013
107 BRAIN OPERATION 3 0.0013
108 BOWEL MOVEMENT IRREGULARITY 10 0.0013
109 POOR QUALITY SLEEP 28 0.0013
110 FORMICATION 9 0.0013
111 FAMILY STRESS 4 0.0013
112 TOOTH FRACTURE 14 0.0013
113 DENTAL CARIES 14 0.0013
114 PRODUCT USE IN UNAPPROVED INDICATION 306 0.0012
115 ANAL INCONTINENCE 11 0.0012
116 SPRUE-LIKE ENTEROPATHY 6 0.0012
117 INFUSION SITE HAEMORRHAGE 4 0.0012
118 FEELING DRUNK 9 0.0012
119 PEPTIC ULCER 4 0.0012
120 SEASONAL ALLERGY 17 0.0012
121 CATHETER SITE HAEMORRHAGE 3 0.0012
122 BRAIN NEOPLASM 11 0.0012
123 ERECTION INCREASED 5 0.0012
124 DRUG TOLERANCE 6 0.0012
125 ANGLE CLOSURE GLAUCOMA 3 0.0012
126 TENSION HEADACHE 5 0.0012
127 HORDEOLUM 5 0.0012
128 IMPAIRED DRIVING ABILITY 13 0.0011
129 DRUG SCREEN POSITIVE 9 0.0011
130 SCOLIOSIS 7 0.0011
131 ABDOMINAL DISCOMFORT 189 0.0011
132 ANIMAL BITE 3 0.0011
133 PRE-EXISTING CONDITION IMPROVED 7 0.0011
134 PRODUCT QUALITY ISSUE 151 0.0011
135 BLEPHAROSPASM 7 0.0011
136 PHOTOPSIA 7 0.0011
137 HYPERACUSIS 4 0.0011
138 INITIAL INSOMNIA 11 0.0011
139 ANAL HAEMORRHAGE 3 0.0011
140 TUBULOINTERSTITIAL NEPHRITIS 20 0.0011
141 SOMNAMBULISM 7 0.0011
142 MATERNAL EXPOSURE TIMING UNSPECIFIED 4 0.0011
143 MICTURITION URGENCY 12 0.0010
144 BACK DISORDER 17 0.0010
145 DISSOCIATION 8 0.0010
146 PARAESTHESIA ORAL 15 0.0010
147 HYPERTONIC BLADDER 3 0.0010
148 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
149 URINE ODOUR ABNORMAL 6 0.0010
150 DECREASED INTEREST 6 0.0010
151 SUSPECTED COUNTERFEIT PRODUCT 4 0.0010
152 SINUS DISORDER 20 0.0010
153 BLADDER DISORDER 10 0.0010
154 ACNE CYSTIC 3 0.0010
155 EMERGENCY CARE 3 0.0010
156 INCREASED TENDENCY TO BRUISE 9 0.0010
157 EUPHORIC MOOD 10 0.0010
158 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
159 INTENTIONAL UNDERDOSE 7 0.0010
160 INFUSION SITE SWELLING 6 0.0010
161 ABDOMINAL PAIN UPPER 196 0.0010
162 INFUSION SITE PRURITUS 3 0.0009
163 CEREBRAL DISORDER 7 0.0009
164 BLADDER PAIN 3 0.0009
165 INTERVERTEBRAL DISC DISORDER 4 0.0009
166 HEADACHE 587 0.0009
167 OVERWEIGHT 5 0.0009
168 HYPOAESTHESIA ORAL 14 0.0009
169 PRODUCT RESIDUE PRESENT 5 0.0009
170 BLOOD MAGNESIUM DECREASED 8 0.0009
171 MUSCLE TIGHTNESS 15 0.0009
172 HYDROCEPHALUS 5 0.0009
173 HAEMORRHAGIC ANAEMIA 4 0.0009
174 WALKING AID USER 6 0.0009
175 GASTROINTESTINAL PAIN 10 0.0009
176 NEAR DEATH EXPERIENCE 3 0.0009
177 DYSMENORRHOEA 12 0.0009
178 OVARIAN CYST 9 0.0009
179 POST-TRAUMATIC STRESS DISORDER 6 0.0009
180 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
181 IRON DEFICIENCY 4 0.0009
182 EXTRA DOSE ADMINISTERED 36 0.0009
183 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 63 0.0009
184 DRUG DEPENDENCE 142 0.0009
185 EXOSTOSIS 8 0.0009
186 SYNOVIAL CYST 4 0.0009
187 HYPERREFLEXIA 3 0.0009
188 TRANSFUSION 9 0.0009
189 CAROTID ARTERY STENOSIS 3 0.0009
190 UMBILICAL HERNIA 4 0.0009
191 INFUSION SITE PAIN 11 0.0009
192 HANGOVER 3 0.0009
193 TIBIA FRACTURE 4 0.0009
194 LACERATION 8 0.0008
195 SKIN TIGHTNESS 4 0.0008
196 ENERGY INCREASED 5 0.0008
197 LIMB INJURY 23 0.0008
198 GASTROOESOPHAGEAL REFLUX DISEASE 68 0.0008
199 PRE-ECLAMPSIA 4 0.0008
200 MACULAR DEGENERATION 10 0.0008
201 UNDERDOSE 61 0.0008
202 LIVER DISORDER 37 0.0008
203 FACIAL BONES FRACTURE 3 0.0008
204 APPARENT DEATH 3 0.0008
205 INTERVERTEBRAL DISC PROTRUSION 18 0.0008
206 DYSPEPSIA 81 0.0008
207 TENSION 5 0.0008
208 QUALITY OF LIFE DECREASED 11 0.0008
209 PAIN IN JAW 23 0.0008
210 SPINAL OPERATION 10 0.0008
211 TINNITUS 37 0.0008
212 INTENTIONAL PRODUCT MISUSE 70 0.0008
213 BLOOD CALCIUM INCREASED 7 0.0008
214 PHOTOPHOBIA 15 0.0008
215 SPINAL OSTEOARTHRITIS 7 0.0008
216 REBOUND EFFECT 9 0.0008
217 HEPATIC NECROSIS 3 0.0008
218 FACE INJURY 3 0.0008
219 INSOMNIA 210 0.0008
220 PARANASAL SINUS HYPERSECRETION 3 0.0008
221 FIBROMYALGIA 19 0.0008
222 ROTATOR CUFF SYNDROME 10 0.0008
223 TOOTHACHE 14 0.0008
224 RESTLESS LEGS SYNDROME 14 0.0008
225 MALABSORPTION 4 0.0008
226 PARTIAL SEIZURES 4 0.0008
227 PRODUCT USE COMPLAINT 12 0.0008
228 DYSGRAPHIA 5 0.0008
229 NERVE COMPRESSION 7 0.0008
230 RENAL CYST 6 0.0008
231 SCIATICA 12 0.0008
232 EXPIRED PRODUCT ADMINISTERED 25 0.0008
233 PRODUCT COMPLAINT 19 0.0007
234 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
235 FOREIGN BODY 3 0.0007
236 HEREDITARY ANGIOEDEMA 8 0.0007
237 FUNGAL SKIN INFECTION 3 0.0007
238 ENURESIS 3 0.0007
239 BRUXISM 4 0.0007
240 RENAL INJURY 22 0.0007
241 ERYTHEMA OF EYELID 4 0.0007
242 NECK PAIN 41 0.0007
243 HYPERSOMNIA 21 0.0007
244 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 52 0.0007
245 ECCHYMOSIS 5 0.0007
246 NONSPECIFIC REACTION 4 0.0007
247 EAR PAIN 14 0.0007
248 EXTRASYSTOLES 5 0.0007
249 RIGHT VENTRICULAR FAILURE 5 0.0007
250 OCULAR DISCOMFORT 8 0.0007
251 PREMATURE LABOUR 4 0.0007
252 HEPATIC PAIN 3 0.0007
253 DERMATITIS CONTACT 8 0.0007
254 HIATUS HERNIA 9 0.0007
255 SKIN ATROPHY 4 0.0007
256 LIVER INJURY 17 0.0007
257 SKIN WARM 4 0.0007
258 FOOT FRACTURE 13 0.0007
259 MELANOCYTIC NAEVUS 3 0.0007
260 DYSPHEMIA 3 0.0007
261 UTERINE LEIOMYOMA 5 0.0007
262 ONYCHOMYCOSIS 3 0.0007
263 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
264 PRODUCT SUBSTITUTION ISSUE 39 0.0007
265 ILL-DEFINED DISORDER 41 0.0007
266 TOOTH DISORDER 15 0.0007
267 PALPITATIONS 79 0.0007
268 BLOOD IRON DECREASED 8 0.0007
269 SINUS HEADACHE 4 0.0007
270 FACIAL PAIN 6 0.0007
271 TENDERNESS 7 0.0007
272 GASTROINTESTINAL INFECTION 6 0.0007
273 PRODUCT ODOUR ABNORMAL 7 0.0007
274 RENAL FAILURE 88 0.0007
275 INCONTINENCE 7 0.0007
276 RENAL PAIN 7 0.0007
277 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
278 EAR DISORDER 3 0.0007
279 IMPAIRED WORK ABILITY 14 0.0007
280 INSURANCE ISSUE 10 0.0007
281 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
282 LOCALISED OEDEMA 3 0.0006
283 ARTHRITIS INFECTIVE 3 0.0006
284 LIMB DISCOMFORT 20 0.0006
285 INCORRECT PRODUCT ADMINISTRATION DURATION 14 0.0006
286 NEPHROPATHY 6 0.0006
287 SPINAL DISORDER 6 0.0006
288 GAIT INABILITY 21 0.0006
289 CYSTITIS 20 0.0006
290 FEELING ABNORMAL 150 0.0006
291 VERTIGO 38 0.0006
292 CONTUSION 60 0.0006
293 HUMERUS FRACTURE 3 0.0006
294 ATELECTASIS 6 0.0006
295 MUSCLE DISORDER 5 0.0006
296 ABNORMAL DREAMS 17 0.0006
297 CHOKING 12 0.0006
298 GOUT 11 0.0006
299 MULTIPLE SCLEROSIS RELAPSE 42 0.0006
300 KIDNEY INFECTION 12 0.0006
301 HOT FLUSH 46 0.0006
302 JOINT STIFFNESS 16 0.0006
303 JOINT INJURY 13 0.0006
304 GASTRITIS 16 0.0006
305 LIVER FUNCTION TEST INCREASED 13 0.0006
306 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
307 PANIC ATTACK 22 0.0006
308 ANEURYSM 3 0.0006
309 BALANCE DISORDER 52 0.0006
310 PRODUCT USE ISSUE 113 0.0006
311 ARTHRITIS 47 0.0006
312 ATRIAL SEPTAL DEFECT 5 0.0006
313 BREAST MASS 4 0.0006
314 EXPOSURE DURING PREGNANCY 37 0.0006
315 DRUG EFFECT DECREASED 32 0.0006
316 PRODUCT ADMINISTRATION ERROR 12 0.0006
317 INFUSION SITE ERYTHEMA 5 0.0006
318 UTERINE PERFORATION 5 0.0006
319 THINKING ABNORMAL 11 0.0006
320 ANXIETY 167 0.0006
321 VITAMIN D DECREASED 5 0.0006
322 WRIST FRACTURE 7 0.0006
323 PERIPHERAL COLDNESS 8 0.0006
324 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
325 TEMPERATURE INTOLERANCE 6 0.0006
326 TOOTH LOSS 12 0.0006
327 INCORRECT DOSE ADMINISTERED 132 0.0006
328 LARGE INTESTINE POLYP 4 0.0006
329 SLEEP APNOEA SYNDROME 11 0.0006
330 LARGE INTESTINE PERFORATION 4 0.0006
331 CHROMATURIA 13 0.0006
332 NERVOUSNESS 30 0.0006
333 ROAD TRAFFIC ACCIDENT 24 0.0006
334 PAPULE 4 0.0006
335 JOINT DISLOCATION 6 0.0006
336 DUODENAL ULCER 4 0.0006
337 IMMUNOSUPPRESSION 5 0.0006
338 PRODUCT COMMUNICATION ISSUE 5 0.0006
339 HEAD DISCOMFORT 10 0.0006
340 HAND FRACTURE 4 0.0006
341 ANORECTAL DISCOMFORT 3 0.0006
342 DIVERTICULUM 4 0.0006
343 RETCHING 12 0.0006
344 BREAST PAIN 6 0.0006
345 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
346 GINGIVITIS 3 0.0006
347 SINUSITIS 57 0.0006
348 HEART RATE INCREASED 55 0.0006
349 PRURITUS GENERALISED 12 0.0006
350 HYPOAESTHESIA 83 0.0006
351 CHEILITIS 3 0.0006
352 HIP SURGERY 3 0.0006
353 MENSTRUATION DELAYED 6 0.0006
354 VISUAL FIELD DEFECT 4 0.0006
355 FAECES DISCOLOURED 12 0.0006
356 MEMORY IMPAIRMENT 76 0.0006
357 HAEMATEMESIS 14 0.0006
358 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 111 0.0005
359 BONE PAIN 32 0.0005
360 ORAL DISORDER 4 0.0005
361 CHOKING SENSATION 3 0.0005
362 HYPERKERATOSIS 3 0.0005
363 BLINDNESS TRANSIENT 4 0.0005
364 IRON DEFICIENCY ANAEMIA 5 0.0005
365 CONSTIPATION 118 0.0005
366 OROPHARYNGEAL PAIN 50 0.0005
367 MEDICATION ERROR 30 0.0005
368 NAUSEA 427 0.0005
369 HEART RATE ABNORMAL 3 0.0005
370 HEAD INJURY 17 0.0005
371 INTERMENSTRUAL BLEEDING 3 0.0005
372 SUNBURN 4 0.0005
373 APPENDICITIS 5 0.0005
374 BACK PAIN 124 0.0005
375 TOOTH INFECTION 7 0.0005
376 TREMOR 88 0.0005
377 FLATULENCE 30 0.0005
378 EAR INFECTION 14 0.0005
379 ILLNESS 54 0.0005
380 MUSCULOSKELETAL DISCOMFORT 9 0.0005
381 HERPES VIRUS INFECTION 3 0.0005
382 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 25 0.0005
383 PHARYNGEAL OEDEMA 8 0.0005
384 THYROID DISORDER 8 0.0005
385 HYPERVENTILATION 3 0.0005
386 MUSCULOSKELETAL CHEST PAIN 8 0.0005
387 SPEECH DISORDER 27 0.0005
388 PARAESTHESIA 81 0.0005
389 DYSSTASIA 15 0.0005
390 IMPAIRED GASTRIC EMPTYING 7 0.0005
391 IRRITABLE BOWEL SYNDROME 11 0.0005
392 AUTOIMMUNE DISORDER 5 0.0005
393 HAEMORRHOIDS 10 0.0005
394 MULTIPLE ALLERGIES 4 0.0005
395 RENAL TUBULAR NECROSIS 5 0.0005
396 COELIAC DISEASE 5 0.0005
397 LYMPHOCYTE COUNT DECREASED 9 0.0005
398 HEPATOMEGALY 5 0.0005
399 THERAPY CHANGE 5 0.0005
400 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
401 URINARY INCONTINENCE 15 0.0005
402 ORAL DISCOMFORT 7 0.0005
403 TRICUSPID VALVE INCOMPETENCE 4 0.0005
404 GINGIVAL PAIN 4 0.0005
405 COORDINATION ABNORMAL 7 0.0005
406 NEPHROLITHIASIS 23 0.0005
407 HEARING IMPAIRED 3 0.0005
408 BLOOD POTASSIUM DECREASED 15 0.0005
409 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
410 SENSORY LOSS 4 0.0005
411 RHINITIS 4 0.0005
412 CRYING 18 0.0005
413 FRUSTRATION TOLERANCE DECREASED 4 0.0005
414 NOCTURIA 6 0.0005
415 BONE DISORDER 9 0.0005
416 RENAL DISORDER 23 0.0005
417 DEPRESSION 112 0.0005
418 EYELID PTOSIS 5 0.0005
419 POST PROCEDURAL INFECTION 4 0.0005
420 MUSCULOSKELETAL STIFFNESS 43 0.0005
421 MOTOR DYSFUNCTION 5 0.0005
422 PRODUCT DOSE OMISSION 32 0.0005
423 ABNORMAL FAECES 4 0.0005
424 SMALL INTESTINAL OBSTRUCTION 6 0.0005
425 EAR DISCOMFORT 5 0.0005
426 RIB FRACTURE 10 0.0005
427 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
428 HEPATIC STEATOSIS 9 0.0005
429 TOOTH EXTRACTION 6 0.0005
430 FATIGUE 375 0.0005
431 DIZZINESS 239 0.0005
432 WEIGHT FLUCTUATION 5 0.0005
433 AMNESIA 31 0.0005
434 WITHDRAWAL SYNDROME 20 0.0005
435 SWELLING FACE 31 0.0005
436 BRAIN OEDEMA 6 0.0005
437 INFLUENZA LIKE ILLNESS 39 0.0005
438 BURNING SENSATION 33 0.0005
439 ACUTE KIDNEY INJURY 72 0.0005
440 PSORIATIC ARTHROPATHY 19 0.0005
441 ACUTE RESPIRATORY FAILURE 9 0.0005
442 SCAR 8 0.0005
443 SOMNOLENCE 94 0.0005
444 ADVERSE EVENT 43 0.0005
445 NIGHT SWEATS 15 0.0005
446 HERNIA 9 0.0005
447 CARDIAC OPERATION 4 0.0005
448 CARDIAC FLUTTER 3 0.0005
449 INJECTION SITE BRUISING 37 0.0005
450 DISTURBANCE IN ATTENTION 25 0.0005
451 DECREASED ACTIVITY 5 0.0005
452 MUSCLE SPASMS 85 0.0005
453 MYOPATHY 4 0.0005
454 MUSCLE STRAIN 4 0.0005
455 HEPATITIS ACUTE 3 0.0005
456 PLATELET COUNT INCREASED 6 0.0005
457 MULTIPLE SCLEROSIS 22 0.0005
458 BIPOLAR DISORDER 5 0.0005
459 GAIT DISTURBANCE 88 0.0005
460 BACK INJURY 5 0.0005
461 PRODUCT DOSE OMISSION IN ERROR 13 0.0005
462 PULMONARY THROMBOSIS 5 0.0005
463 CHOLELITHIASIS 15 0.0005
464 NAIL DISORDER 4 0.0005
465 EYE SWELLING 17 0.0005
466 IMPAIRED HEALING 15 0.0005
467 BEDRIDDEN 6 0.0005
468 POLLAKIURIA 19 0.0005
469 VOMITING 214 0.0005
470 STAPHYLOCOCCAL INFECTION 15 0.0005
471 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
472 DEPRESSED MOOD 24 0.0005
473 UPPER LIMB FRACTURE 9 0.0005
474 COGNITIVE DISORDER 21 0.0004
475 EYE HAEMORRHAGE 6 0.0004
476 THERAPY CESSATION 23 0.0004
477 PERIPHERAL SWELLING 69 0.0004
478 MALIGNANT MELANOMA 6 0.0004
479 DYSPHONIA 26 0.0004
480 FEEDING DISORDER 9 0.0004
481 ANGER 15 0.0004
482 CHEST PAIN 82 0.0004
483 DYSPHAGIA 42 0.0004
484 PNEUMOTHORAX 7 0.0004
485 ABNORMAL LOSS OF WEIGHT 3 0.0004
486 CHEST DISCOMFORT 45 0.0004
487 GINGIVAL BLEEDING 6 0.0004
488 MOOD SWINGS 14 0.0004
489 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
490 ACUTE HEPATIC FAILURE 6 0.0004
491 MUSCULOSKELETAL PAIN 23 0.0004
492 FALL 146 0.0004
493 HYPOTHYROIDISM 14 0.0004
494 BLOOD PRESSURE INCREASED 67 0.0004
495 LOSS OF CONSCIOUSNESS 56 0.0004
496 SENSORY DISTURBANCE 7 0.0004
497 CHILLS 51 0.0004
498 HAEMATOCHEZIA 24 0.0004
499 LYMPHOEDEMA 3 0.0004
500 UROSEPSIS 4 0.0004
501 FEELING COLD 12 0.0004
502 HUNGER 6 0.0004
503 APHONIA 6 0.0004
504 MYALGIA 73 0.0004
505 RASH MACULAR 15 0.0004
506 HEPATIC ENCEPHALOPATHY 4 0.0004
507 ARTERIOSCLEROSIS 4 0.0004
508 GASTROINTESTINAL DISORDER 38 0.0004
509 ADVERSE DRUG REACTION 38 0.0004
510 THERAPEUTIC RESPONSE SHORTENED 14 0.0004
511 OVERDOSE 91 0.0004
512 MALAISE 185 0.0004
513 LIP SWELLING 14 0.0004
514 COAGULOPATHY 7 0.0004
515 APPLICATION SITE ERYTHEMA 11 0.0004
516 PARALYSIS 6 0.0004
517 CEREBRAL HAEMORRHAGE 15 0.0004
518 HYPERLIPIDAEMIA 5 0.0004
519 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
520 GLAUCOMA 8 0.0004
521 HEPATITIS C 5 0.0004
522 SKIN DISCOLOURATION 19 0.0004
523 HEMIPARESIS 7 0.0004
524 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
525 APATHY 6 0.0004
526 MAJOR DEPRESSION 3 0.0004
527 NO THERAPEUTIC RESPONSE 5 0.0004
528 PHARYNGEAL SWELLING 4 0.0004
529 FEELING HOT 25 0.0004
530 MENORRHAGIA 8 0.0004
531 THROAT TIGHTNESS 11 0.0004
532 DYSGEUSIA 30 0.0004
533 MOOD ALTERED 11 0.0004
534 CYST 5 0.0004
535 INABILITY TO AFFORD MEDICATION 4 0.0004
536 THROAT IRRITATION 18 0.0004
537 SKIN LESION 11 0.0004
538 OSTEOARTHRITIS 17 0.0004
539 HYDRONEPHROSIS 3 0.0004
540 PAIN IN EXTREMITY 118 0.0004
541 SPINAL FRACTURE 8 0.0004
542 BRAIN INJURY 4 0.0004
543 PAIN 245 0.0004
544 SEIZURE 46 0.0004
545 APHASIA 12 0.0004
546 DIVERTICULITIS 11 0.0004
547 ABDOMINAL PAIN LOWER 10 0.0004
548 MUSCLE ATROPHY 5 0.0004
549 VISION BLURRED 54 0.0004
550 TOOTH ABSCESS 4 0.0004
551 ABDOMINAL DISTENSION 41 0.0004
552 BRONCHITIS 29 0.0004
553 FUNGAL INFECTION 13 0.0004
554 EYE PAIN 22 0.0004
555 SKIN DISORDER 13 0.0004
556 EMOTIONAL DISORDER 12 0.0004
557 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
558 EYE PRURITUS 13 0.0004
559 OSTEOMYELITIS 7 0.0004
560 EYE DISCHARGE 4 0.0004
561 BASAL CELL CARCINOMA 6 0.0004
562 RESPIRATORY TRACT INFECTION 10 0.0004
563 GASTROINTESTINAL HAEMORRHAGE 32 0.0004
564 SLEEP DISORDER 27 0.0004
565 DRUG ADMINISTERED AT INAPPROPRIATE SITE 4 0.0004
566 DISEASE RECURRENCE 18 0.0004
567 THERAPY NON-RESPONDER 17 0.0004
568 ADVERSE REACTION 5 0.0004
569 ABSCESS 6 0.0004
570 NIGHTMARE 13 0.0004
571 MIDDLE INSOMNIA 7 0.0004
572 BODY HEIGHT DECREASED 4 0.0004
573 FLUSHING 38 0.0004
574 HAIR TEXTURE ABNORMAL 5 0.0004
575 INJECTION SITE PRURITUS 25 0.0004
576 LABORATORY TEST ABNORMAL 11 0.0004
577 ASTHMA 42 0.0004
578 SKIN CANCER 8 0.0004
579 INJECTION SITE ERYTHEMA 46 0.0004
580 PRESYNCOPE 9 0.0004
581 PRODUCT TASTE ABNORMAL 5 0.0004
582 BLOOD URINE PRESENT 7 0.0004
583 VAGINAL HAEMORRHAGE 16 0.0004
584 CONDITION AGGRAVATED 112 0.0004
585 DECUBITUS ULCER 3 0.0004
586 INCREASED APPETITE 7 0.0004
587 METASTASES TO BONE 6 0.0004
588 ARTHRALGIA 152 0.0004
589 HYPERAESTHESIA 3 0.0004
590 LETHARGY 21 0.0004
591 BLOOD GLUCOSE FLUCTUATION 4 0.0004
592 ESCHERICHIA INFECTION 3 0.0004
593 DRUG PRESCRIBING ERROR 7 0.0004
594 URTICARIA 61 0.0004
595 HAIR DISORDER 3 0.0004
596 MOBILITY DECREASED 26 0.0004
597 ERUCTATION 7 0.0004
598 VISUAL ACUITY REDUCED 12 0.0004
599 NERVE INJURY 4 0.0004
600 URINARY RETENTION 12 0.0004
601 HYPOMAGNESAEMIA 5 0.0004
602 ORAL PAIN 8 0.0004
603 CARPAL TUNNEL SYNDROME 5 0.0004
604 DRUG USE DISORDER 3 0.0004
605 TYPE 2 DIABETES MELLITUS 12 0.0004
606 BLOOD CALCIUM DECREASED 4 0.0004
607 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
608 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
609 INTENTIONAL PRODUCT USE ISSUE 31 0.0004
610 CATARACT 21 0.0004
611 SCAB 4 0.0004
612 CHOLECYSTECTOMY 4 0.0003
613 RED BLOOD CELL COUNT DECREASED 10 0.0003
614 DECREASED APPETITE 81 0.0003
615 FULL BLOOD COUNT DECREASED 7 0.0003
616 MUSCLE TWITCHING 8 0.0003
617 HYSTERECTOMY 3 0.0003
618 DEHYDRATION 46 0.0003
619 MENTAL DISORDER 15 0.0003
620 HAEMORRHAGE 36 0.0003
621 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
622 DEAFNESS 9 0.0003
623 LOCAL SWELLING 6 0.0003
624 CAESAREAN SECTION 4 0.0003
625 MUSCULAR WEAKNESS 39 0.0003
626 SWELLING 32 0.0003
627 GROIN PAIN 3 0.0003
628 SPLENOMEGALY 4 0.0003
629 GRIP STRENGTH DECREASED 3 0.0003
630 INFLUENZA 38 0.0003
631 HYPERTENSION 72 0.0003
632 LYMPHADENOPATHY 12 0.0003
633 SKIN HAEMORRHAGE 5 0.0003
634 ATAXIA 4 0.0003
635 CHOLECYSTITIS 4 0.0003
636 THROMBOSIS 27 0.0003
637 FEAR 9 0.0003
638 MYOSITIS 3 0.0003
639 EPISTAXIS 25 0.0003
640 DRY MOUTH 27 0.0003
641 DRUG DOSE OMISSION 55 0.0003
642 GASTROENTERITIS VIRAL 6 0.0003
643 HALLUCINATION 25 0.0003
644 HALLUCINATION, VISUAL 7 0.0003
645 VISUAL IMPAIRMENT 41 0.0003
646 HERPES ZOSTER 19 0.0003
647 PELVIC PAIN 6 0.0003
648 DIARRHOEA 213 0.0003
649 BLOOD COUNT ABNORMAL 5 0.0003
650 ADRENAL INSUFFICIENCY 4 0.0003
651 OSTEOPENIA 5 0.0003
652 EATING DISORDER 7 0.0003
653 URINARY TRACT INFECTION 56 0.0003
654 DIABETES MELLITUS 25 0.0003
655 ASTHENIA 123 0.0003
656 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
657 DYSURIA 12 0.0003
658 ALOPECIA 64 0.0003
659 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
660 NASOPHARYNGITIS 60 0.0003
661 MENTAL STATUS CHANGES 9 0.0003
662 ANKLE FRACTURE 5 0.0003
663 TENDONITIS 5 0.0003
664 WOUND 9 0.0003
665 ILEUS 4 0.0003
666 EJECTION FRACTION DECREASED 5 0.0003
667 HAIR COLOUR CHANGES 4 0.0003
668 COUGH 90 0.0003
669 THERAPY PARTIAL RESPONDER 5 0.0003
670 FLANK PAIN 3 0.0003
671 FOETAL EXPOSURE DURING PREGNANCY 26 0.0003
672 INTESTINAL OBSTRUCTION 12 0.0003
673 CELLULITIS 16 0.0003
674 SUICIDAL IDEATION 29 0.0003
675 ACNE 24 0.0003
676 NEUROPATHY PERIPHERAL 30 0.0003
677 HEPATOTOXICITY 7 0.0003
678 MATERNAL EXPOSURE DURING PREGNANCY 28 0.0003
679 RASH PRURITIC 17 0.0003
680 GLOSSODYNIA 7 0.0003
681 POST PROCEDURAL COMPLICATION 6 0.0003
682 AFFECT LABILITY 3 0.0003
683 MOVEMENT DISORDER 10 0.0003
684 DRUG INTOLERANCE 30 0.0003
685 HYPERHIDROSIS 40 0.0003
686 HEART RATE IRREGULAR 7 0.0003
687 RHINORRHOEA 20 0.0003
688 DIZZINESS POSTURAL 3 0.0003
689 PRODUCT ADHESION ISSUE 11 0.0003
690 NASAL CONGESTION 18 0.0003
691 PULMONARY EMBOLISM 29 0.0003
692 BODY TEMPERATURE DECREASED 3 0.0003
693 PSYCHOTIC DISORDER 9 0.0003
694 WEIGHT DECREASED 85 0.0003
695 HOSPICE CARE 3 0.0003
696 WEIGHT INCREASED 68 0.0003
697 DISABILITY 6 0.0003
698 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
699 RECTAL HAEMORRHAGE 13 0.0003
700 HAEMATOCRIT DECREASED 6 0.0003
701 C-REACTIVE PROTEIN INCREASED 11 0.0003
702 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
703 CEREBROVASCULAR ACCIDENT 51 0.0003
704 PRESCRIBED UNDERDOSE 6 0.0003
705 ACCIDENTAL OVERDOSE 11 0.0003
706 STOMATITIS 18 0.0003
707 HYPERSENSITIVITY 55 0.0003
708 CANDIDA INFECTION 5 0.0003
709 DRUG LEVEL DECREASED 3 0.0003
710 BLINDNESS 12 0.0003
711 BODY TEMPERATURE INCREASED 6 0.0003
712 HEPATIC ENZYME INCREASED 20 0.0003
713 DYSPNOEA EXERTIONAL 11 0.0003
714 OSTEOPOROSIS 12 0.0003
715 PSORIASIS 38 0.0003
716 APPLICATION SITE RASH 4 0.0003
717 FEMUR FRACTURE 9 0.0003
718 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
719 COLITIS 11 0.0003
720 PROCEDURAL PAIN 8 0.0003
721 ARTHROPATHY 16 0.0003
722 MASS 4 0.0003
723 FOLLICULITIS 3 0.0003
724 AMENORRHOEA 5 0.0003
725 MOUTH ULCERATION 6 0.0003
726 BLOOD TEST ABNORMAL 4 0.0003
727 INJURY 20 0.0003
728 FULL BLOOD COUNT ABNORMAL 3 0.0003
729 ABASIA 7 0.0003
730 IRRITABILITY 17 0.0003
731 AGEUSIA 7 0.0003
732 GALLBLADDER DISORDER 5 0.0003
733 THIRST 5 0.0003
734 SYNCOPE 28 0.0003
735 ABDOMINAL PAIN 65 0.0003
736 IMPAIRED QUALITY OF LIFE 4 0.0003
737 OEDEMA 15 0.0003
738 DEVICE DISLOCATION 12 0.0003
739 FLUID RETENTION 14 0.0003
740 LIVER FUNCTION TEST ABNORMAL 8 0.0003
741 GASTROENTERITIS 4 0.0003
742 HYPOPHAGIA 7 0.0003
743 EYE DISORDER 9 0.0003
744 RESTLESSNESS 10 0.0003
745 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
746 HAEMOGLOBIN DECREASED 28 0.0003
747 UNRESPONSIVE TO STIMULI 7 0.0003
748 FOOT DEFORMITY 3 0.0003
749 PRURITUS 104 0.0003
750 DYSPNOEA 153 0.0003
751 PHARMACEUTICAL PRODUCT COMPLAINT 7 0.0003
752 DIPLOPIA 7 0.0003
753 COLON CANCER 4 0.0003
754 RASH PAPULAR 6 0.0003
755 SEDATION 7 0.0003
756 CARDIAC DISORDER 25 0.0003
757 ATRIAL FIBRILLATION 26 0.0003
758 ANHEDONIA 7 0.0003
759 BONE LOSS 4 0.0003
760 EYE INFECTION 3 0.0003
761 HEPATIC FAILURE 8 0.0003
762 SKIN BURNING SENSATION 19 0.0003
763 JOINT SWELLING 32 0.0003
764 UNEVALUABLE EVENT 20 0.0003
765 CORONARY ARTERY DISEASE 8 0.0003
766 ECONOMIC PROBLEM 4 0.0003
767 THERAPEUTIC RESPONSE DECREASED 16 0.0003
768 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
769 MYOCARDIAL ISCHAEMIA 3 0.0003
770 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
771 ERYTHEMA 54 0.0003
772 MUSCULOSKELETAL DISORDER 5 0.0003
773 INTERNAL HAEMORRHAGE 3 0.0003
774 DISCOMFORT 16 0.0003
775 DEEP VEIN THROMBOSIS 17 0.0003
776 MENSTRUATION IRREGULAR 7 0.0003
777 INJECTION SITE SWELLING 20 0.0003
778 NEOPLASM 3 0.0003
779 LOWER LIMB FRACTURE 5 0.0003
780 DEVICE RELATED INFECTION 4 0.0003
781 MADAROSIS 3 0.0003
782 PRESCRIBED OVERDOSE 5 0.0003
783 WHITE BLOOD CELL COUNT DECREASED 28 0.0003
784 DEVICE DIFFICULT TO USE 17 0.0003
785 DEVICE MALFUNCTION 18 0.0003
786 ORAL HERPES 5 0.0003
787 SWOLLEN TONGUE 8 0.0003
788 BRAIN FOG 4 0.0003
789 PRODUCT DOSE OMISSION ISSUE 75 0.0003
790 WHEEZING 15 0.0003
791 BLOOD PRESSURE ABNORMAL 5 0.0003
792 OBESITY 4 0.0003
793 INJECTION SITE PAIN 77 0.0003
794 HAEMOPTYSIS 7 0.0003
795 DEMENTIA 7 0.0003
796 PREGNANCY 5 0.0002
797 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
798 MENTAL IMPAIRMENT 6 0.0002
799 NEURALGIA 6 0.0002
800 RHEUMATOID ARTHRITIS 28 0.0002
801 ANAEMIA 47 0.0002
802 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
803 INJECTION SITE URTICARIA 6 0.0002
804 MULTIPLE FRACTURES 4 0.0002
805 INJECTION SITE WARMTH 5 0.0002
806 HYPERCALCAEMIA 3 0.0002
807 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
808 CONFUSIONAL STATE 39 0.0002
809 PULMONARY HYPERTENSION 5 0.0002
810 INTENTIONAL DRUG MISUSE 5 0.0002
811 INJECTION SITE IRRITATION 3 0.0002
812 INTRAOCULAR PRESSURE INCREASED 3 0.0002
813 METRORRHAGIA 4 0.0002
814 INTENTIONAL OVERDOSE 15 0.0002
815 HAEMATURIA 8 0.0002
816 SKIN ULCER 6 0.0002
817 PARANOIA 4 0.0002
818 LACRIMATION INCREASED 7 0.0002
819 HAEMATOMA 6 0.0002
820 BLISTER 13 0.0002
821 INJECTION SITE INDURATION 3 0.0002
822 PRODUCTIVE COUGH 11 0.0002
823 NODULE 3 0.0002
824 OEDEMA PERIPHERAL 28 0.0002
825 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
826 EPILEPSY 7 0.0002
827 INJECTION SITE RASH 7 0.0002
828 ANKYLOSING SPONDYLITIS 3 0.0002
829 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
830 APPLICATION SITE PAIN 5 0.0002
831 JAUNDICE 6 0.0002
832 RASH 97 0.0002
833 HOSPITALISATION 34 0.0002
834 LEUKOCYTOSIS 4 0.0002
835 APPLICATION SITE PRURITUS 5 0.0002
836 PRODUCT AVAILABILITY ISSUE 5 0.0002
837 RESPIRATORY FAILURE 16 0.0002
838 INJECTION SITE REACTION 15 0.0002
839 MYOCARDIAL INFARCTION 38 0.0002
840 HIP FRACTURE 7 0.0002
841 PRODUCT STORAGE ERROR 19 0.0002
842 COVID-19 38 0.0002
843 INJECTION SITE MASS 8 0.0002
844 BLOOD CHOLESTEROL INCREASED 10 0.0002
845 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
846 DEVICE OCCLUSION 3 0.0002
847 BLINDNESS UNILATERAL 3 0.0002
848 DYSARTHRIA 8 0.0002
849 CARDIAC FAILURE CONGESTIVE 17 0.0002
850 OCULAR HYPERAEMIA 10 0.0002
851 VIRAL INFECTION 7 0.0002
852 THERAPY INTERRUPTED 15 0.0002
853 NEOPLASM MALIGNANT 14 0.0002
854 ANGINA PECTORIS 6 0.0002
855 RASH ERYTHEMATOUS 10 0.0002
856 HYPOACUSIS 9 0.0002
857 BLOOD PRESSURE FLUCTUATION 5 0.0002
858 PYREXIA 72 0.0002
859 INFECTION 30 0.0002
860 HYPERTHYROIDISM 3 0.0002
861 LOCALISED INFECTION 5 0.0002
862 HYPOKINESIA 3 0.0002
863 PLATELET COUNT DECREASED 22 0.0002
864 DYSTONIA 4 0.0002
865 DRUG WITHDRAWAL SYNDROME 18 0.0002
866 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
867 DISORIENTATION 8 0.0002
868 IMMUNODEFICIENCY 3 0.0002
869 TREATMENT NONCOMPLIANCE 11 0.0002
870 PULMONARY OEDEMA 9 0.0002
871 HAEMORRHAGE INTRACRANIAL 3 0.0002
872 DRY EYE 10 0.0002
873 INJECTION SITE HAEMORRHAGE 16 0.0002
874 HEART RATE DECREASED 7 0.0002
875 INTENTIONAL SELF-INJURY 4 0.0002
876 BONE MARROW FAILURE 4 0.0002
877 INFUSION RELATED REACTION 13 0.0002
878 OFF LABEL USE 171 0.0002
879 ERECTILE DYSFUNCTION 5 0.0002
880 PNEUMONIA 63 0.0002
881 INFLAMMATION 10 0.0002
882 RASH GENERALISED 5 0.0002
883 DRUG DOSE OMISSION BY DEVICE 15 0.0002
884 CYANOSIS 3 0.0002
885 AGITATION 14 0.0002
886 HALLUCINATION, AUDITORY 3 0.0002
887 SURGERY 11 0.0002
888 PALLOR 5 0.0002
889 PRODUCT PRESCRIBING ISSUE 4 0.0002
890 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
891 SNEEZING 4 0.0002
892 PANCREATITIS ACUTE 4 0.0002
893 FACE OEDEMA 3 0.0002
894 SKIN EXFOLIATION 15 0.0002
895 TARDIVE DYSKINESIA 5 0.0002
896 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
897 HYPOTENSION 35 0.0002
898 PERICARDIAL EFFUSION 4 0.0002
899 DRY SKIN 23 0.0002
900 ORTHOSTATIC HYPOTENSION 3 0.0002
901 DEVICE USE ISSUE 3 0.0002
902 EOSINOPHILIA 3 0.0002
903 COLD SWEAT 3 0.0002
904 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
905 TREATMENT FAILURE 14 0.0002
906 TACHYCARDIA 15 0.0002
907 ISCHAEMIC STROKE 3 0.0002
908 COMA 8 0.0002
909 PRODUCT PRESCRIBING ERROR 4 0.0002
910 RENAL IMPAIRMENT 14 0.0002
911 BLOOD PRESSURE DECREASED 11 0.0002
912 PLEURAL EFFUSION 10 0.0002
913 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
914 BLOOD GLUCOSE ABNORMAL 3 0.0002
915 BACTERIAL INFECTION 3 0.0002
916 NERVOUS SYSTEM DISORDER 5 0.0002
917 DRUG-INDUCED LIVER INJURY 5 0.0002
918 BLOOD SODIUM DECREASED 3 0.0002
919 HEPATITIS 4 0.0002
920 DRUG RESISTANCE 4 0.0002
921 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
922 ANAPHYLACTIC SHOCK 4 0.0002
923 HYPOKALAEMIA 7 0.0002
924 DRUG INTERACTION 24 0.0002
925 ABORTION SPONTANEOUS 6 0.0001
926 EMOTIONAL DISTRESS 18 0.0001
927 PAIN OF SKIN 4 0.0001
928 ARRHYTHMIA 7 0.0001
929 DYSKINESIA 6 0.0001
930 INJURY ASSOCIATED WITH DEVICE 3 0.0001
931 BLOOD GLUCOSE DECREASED 7 0.0001
932 DISEASE PROGRESSION 17 0.0001
933 DERMATITIS 3 0.0001
934 LUNG DISORDER 7 0.0001
935 KNEE ARTHROPLASTY 3 0.0001
936 INTENTIONAL DOSE OMISSION 4 0.0001
937 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
938 DEVICE LEAKAGE 6 0.0001
939 MELAENA 3 0.0001
940 COLITIS ULCERATIVE 6 0.0001
941 SUICIDE ATTEMPT 8 0.0001
942 SKIN IRRITATION 6 0.0001
943 DEPENDENCE 7 0.0001
944 ANAPHYLACTIC REACTION 7 0.0001
945 ABNORMAL BEHAVIOUR 5 0.0001
946 METABOLIC ACIDOSIS 4 0.0001
947 CEREBRAL INFARCTION 3 0.0001
948 BLOOD GLUCOSE INCREASED 23 0.0001
949 EYE IRRITATION 7 0.0001
950 OSTEONECROSIS OF JAW 3 0.0001
951 RHABDOMYOLYSIS 5 0.0001
952 AGGRESSION 6 0.0001
953 GASTRIC CANCER 3 0.0001
954 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
955 HYPOXIA 4 0.0001
956 PANCREATITIS 6 0.0001
957 DEVICE ISSUE 10 0.0001
958 FREQUENT BOWEL MOVEMENTS 3 0.0001
959 HYPERGLYCAEMIA 4 0.0001
960 SEPSIS 12 0.0001
961 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
962 OXYGEN SATURATION DECREASED 6 0.0001
963 NEEDLE ISSUE 3 0.0001
964 NEUTROPHIL COUNT DECREASED 4 0.0001
965 BONE DENSITY DECREASED 3 0.0001
966 DERMATITIS ATOPIC 5 0.0001
967 RENAL FAILURE ACUTE 4 0.0001
968 ANGIOEDEMA 4 0.0001
969 CONVULSION 5 0.0001
970 CARDIAC FAILURE 7 0.0001
971 DEVICE USE ERROR 3 0.0001
972 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
973 HYPOGLYCAEMIA 4 0.0001
974 NEUTROPENIA 11 0.0001
975 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
976 ECZEMA 4 0.0001
977 BRADYCARDIA 4 0.0001
978 DEVICE BREAKAGE 3 0.0001
979 LUNG NEOPLASM MALIGNANT 3 0.0001
980 DRUG ABUSE 6 0.0001
981 DEATH 56 0.0001
982 THROMBOCYTOPENIA 7 0.0001
983 DEVICE EXPULSION 4 0.0001
984 BLOOD CREATININE INCREASED 4 0.0001
985 TOXICITY TO VARIOUS AGENTS 10 0.0001
986 PANCYTOPENIA 3 0.0001
987 BREAST CANCER 5 0.0001
988 CARDIAC ARREST 4 0.0000
989 NO ADVERSE EVENT 7 0.0000